Clinical factor | Crowe I (65 hips) | Crowe II (61 hips) | Crowe III (69 hips) | Crowe IV (212 hips) | p |
---|---|---|---|---|---|
Hip operation history (no. [%]) | 10 | 14 | 16 | 43 | .663 |
Unilateral DDH | |||||
Postoperative inpatient days† (d) | 10.39 ± 6.00 | 7.89 ± 2.76 | 8.24 ± 4.49 | 9.43 ± 4.26 | .069 |
Surgical time† (min) | 125.78 ± 46.29 | 148.47 ± 65.07 | 133.51 ± 48.71 | 168.86 ± 65.89 | .000* |
Blood loss† (mL) | 442.61 ± 343.38 | 442.22 ± 310.05 | 497.96 ± 362.57 | 616.21 ± 455.02 | .013* |
Blood transfusion† (mL) | 235.87 ± 356.50 | 335.44 ± 423.07 | 206.73 ± 297.89 | 510.07 ± 718.81 | .002* |
Osteotomy (no. [%]) | 0 | 9 | 11 | 124 | .000* |
Osteotomy length† (cm) | 0 | 2.11 ± 1.29 | 2.32 ± 0.93 | 3.44 ± 1.20 | .000* |
Acetabular prosthesis position (no. [%]) | .000* | ||||
Crowe I | 44 | 56 | 43 | 197 | |
Crowe II | 21 | 5 | 20 | 11 | |
Crowe III | 0 | 0 | 6 | 3 | |
Crowe IV | 0 | 0 | 0 | 1 | |
Acetabular prosthesis (no. [%]) | .000* | ||||
Duraloc | 12 | 13 | 20 | 66 | |
Betacup | 29 | 20 | 7 | 5 | |
Combicup | 15 | 17 | 27 | 53 | |
Pinnacle | 9 | 11 | 15 | 88 | |
Femoral prosthesis (no. [%]) | .000* | ||||
LCU | 31 | 28 | 27 | 18 | |
S-Rom | 34 | 29 | 40 | 169 | |
Corail | 0 | 4 | 2 | 25 | |
Acetabular liner (no. [%]) | .177 | ||||
MOP | 3 | 3 | 6 | 22 | |
3rd-COC | 7 | 10 | 6 | 39 | |
4th-COC | 55 | 48 | 57 | 151 | |
Revision hip (no. [%]) | .449 | ||||
Periprosthetic fractures | 0 | 0 | 2 | 3 | |
Periprosthetic infection | 0 | 0 | 0 | 1 | |
Polyethylene lining wear | 0 | 0 | 0 | 2 | |
Complications (no. [%]) | .826 | ||||
Postoperative dislocation | 0 | 0 | 0 | 2 | |
Limited flexion | 0 | 0 | 0 | 2 | |
Limp | 28 | 19 | 21 | 72 | |
Knee valgus | 13 | 8 | 9 | 46 | |
Knee pain | 2 | 1 | 3 | 3 | |
Thigh pain (distal femoral prosthesis) | 4 | 1 | 2 | 4 | |
Hip abnormal noise | 3 | 1 | 2 | 13 |